Our study showed, for the first time, that FXR is highly expressed in human pancreatic adenocarcinoma specimens and in five different human pancreatic cancer cell lines tested, suggesting that FXR could be important in human pancreatic cancer progression. The gene discussed is NR1H4; the disease is pancreatic adenocarcinoma.